Veracyte (formerly HaliodDx) is a key player in the MI ecosystem that allows both personalized immunotherapies utilization and acceleration of their development.
Vincent FERT
Veracyte
The Explore covid-19 project was born from combining the forces of Marseille Immunopôle. It should lead us to better understand this new disease and improve the prognosis of our patients.
Julien CARVELLI
AP-HM
We and our patients are resolutely committed to the Marseille Immunopôle; patients no longer wish to be simple "providers of biological samples", but full participants in the research process.
Jean-Robert HARLÉ
AMU, AP-HM
MI today is a great accomplishment as it brings together for the first time all the expertise in immunology but it is above a new strategic step for all Marseille immunology players
Cathy LAPORTE
Marseille Immunopôle
MI both accelerates research and development in immuno-oncology and offers cancer patients more options in terms of diagnostics and treatments, as well as more innovative clinical trials.
Fabrice BARLESI
Université Paris-Saclay, Gustave Roussy, The Pioneer Project
“Our immunotherapy antibodies are positioned at the crossroads of two immunology fields with high potential: the γ9δ2 T cells and a novel superfamily of immunomodulators, butyrophilins”
Pierre d’EPENOUX
Imcheck Therapeutics
Marseille Immunopole is born from the will of all partners to do even better and progress faster, and thus allow patients always to keep one step ahead of the disease.
Éric VIVIER
AMU, AP-HM, CIML, INNATE PHARMA
MI-mAbs allows researchers to validate the therapeutic potential of their discovery and permits industrials to focus their efforts on the most promising drug candidate
Francois ROMAGNÉ
AMU, MI-mAbs
Thanks to this unprecedented alliance of researchers, clinicians, technological platforms and industrials we should be able to quickly do much better
Vincent BARLOGIS
AP-HM
Today Marseille Immunopôle is a great opportunity to challenge our discipline with novel perspectives.
Daniel OLIVE
AMU, IPC, CRCM
The Pioneer Project draws on the collaborative environment of Marseille Immunopôle, which brings together clinicians, academics and industry players committed to the benefit of patients
Laurent GREILLIER
AP-HM, AMU
We have developed a library of human tumors xenografted on immunodepressed mice
Michel IOVANNA JUAN
AMU, IPC, CRCM
Understanding its mechanisms of action and proposing new diagnostic and therapeutic solutions is the ambitious project that we set with my team.
Marcel BLOT-CHABAUD
VRCM
Together, we pursue a simple goal: to better understand the alterations of energetic metabolism in pancreatic cancer cells
Alice CARRIER
AMU, IPC, CRCM